Search for Clinical Trial Results

Sponsored By

Mixed Tumor, Mesodermal - 9 Studies Found

Status Study
Terminated Study Name: Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy
Condition: Uterine Neoplasms
Date: 2007-07-19
Interventions:
  • Drug: Carboplatin AUC 5 by vei
Completed Study Name: A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Condition: Uterine Cancer
Date: 2005-10-03
Interventions:
  • Drug: Ifosfamide Ifosfamide 1.
Terminated Study Name: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
Condition:
  • Ovarian Cancer
  • Primary Peritoneal Carcinoma
  • Fallopian Tube
    Date: 2006-05-05
    Interventions:
    • Drug: Paclitaxel Other Name: T
Terminated Study Name: Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Date: 2000-11-06
Interventions: Drug: topotecan hydrochloride
Completed Study Name: Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Condition: Sarcoma
Date: 1999-11-01
Interventions:
  • Biological: filgrastim
  • Drug: ifosfamide
Completed Study Name: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
Condition:
  • Ovarian Carcinosarcoma
  • Recurrent Fallopian Tube Carcinoma

  • Date: 2009-08-06
    Interventions:
    • Drug: Paclitaxel Given IV
Completed Study Name: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
Condition: Mixed Tumor, Mullerian
Date: 2007-07-16
Interventions:
  • Drug: Carboplatin AUC 5 By Vei
Completed Study Name: Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Condition: Tumor
Date: 2006-12-18
Interventions:
  • Drug: belinostat 300, 600, or

Completed Study Name: Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Condition:
  • Solid Tumor
  • Lymphoma

Date: 2006-12-18
Interventions: Drug: oral belinostat oral belinostat dosed once or twice daily at continuous and discontinuous dosing s